71 related articles for article (PubMed ID: 11411202)
1. Viral dynamics in hepatitis C.
Kershenobich D; Henonin CH
Isr Med Assoc J; 2001 May; 3(5):360-3. PubMed ID: 11411202
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture.
Bartenschlager R
Curr Opin Microbiol; 2006 Aug; 9(4):416-22. PubMed ID: 16814596
[TBL] [Abstract][Full Text] [Related]
3. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.
Boulestin A; Kamar N; Sandres-Sauné K; Legrand-Abravanel F; Alric L; Vinel JP; Rostaing L; Izopet J
J Med Virol; 2006 Mar; 78(3):365-71. PubMed ID: 16419107
[TBL] [Abstract][Full Text] [Related]
4. Mathematical modeling of HCV infection and treatment.
Dahari H; Shudo E; Ribeiro RM; Perelson AS
Methods Mol Biol; 2009; 510():439-53. PubMed ID: 19009281
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection.
Aberle JH; Formann E; Steindl-Munda P; Weseslindtner L; Gurguta C; Perstinger G; Grilnberger E; Laferl H; Dienes HP; Popow-Kraupp T; Ferenci P; Holzmann H
J Clin Virol; 2006 May; 36(1):24-31. PubMed ID: 16483838
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
Deterding K; Tegtmeyer B; Cornberg M; Hadem J; Potthoff A; Böker KH; Tillmann HL; Manns MP; Wedemeyer H
J Hepatol; 2006 Dec; 45(6):770-8. PubMed ID: 17034895
[TBL] [Abstract][Full Text] [Related]
8. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
9. New kinetic models for the hepatitis C virus.
Perelson AS; Herrmann E; Micol F; Zeuzem S
Hepatology; 2005 Oct; 42(4):749-54. PubMed ID: 16175615
[TBL] [Abstract][Full Text] [Related]
10. Convert hepatitis C virus into a non-enveloped virus like hepatitis A, by targeting its envelope rather than the RNA.
Helmy A
Med Hypotheses; 2006; 66(4):847-50. PubMed ID: 16229965
[TBL] [Abstract][Full Text] [Related]
11. Evasion of host immune surveillance by hepatitis C virus: potential roles in viral persistence.
Moorman JP; Joo M; Hahn YS
Arch Immunol Ther Exp (Warsz); 2001; 49(3):189-94. PubMed ID: 11478392
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees.
Major ME; Dahari H; Mihalik K; Puig M; Rice CM; Neumann AU; Feinstone SM
Hepatology; 2004 Jun; 39(6):1709-20. PubMed ID: 15185313
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment.
Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Bartolomé J; Carreño V
Clin Infect Dis; 2006 Nov; 43(10):1277-83. PubMed ID: 17051492
[TBL] [Abstract][Full Text] [Related]
14. Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis.
Watkins-Riedel T; Ferenci P; Steindl-Munda P; Gschwantler M; Mueller C; Woegerbauer M
Clin Infect Dis; 2004 Dec; 39(12):1754-60. PubMed ID: 15578395
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury.
Rosen HR
Liver Transpl; 2003 Nov; 9(11):S35-43. PubMed ID: 14586893
[TBL] [Abstract][Full Text] [Related]
16. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon.
Hiraga N; Imamura M; Tsuge M; Noguchi C; Takahashi S; Iwao E; Fujimoto Y; Abe H; Maekawa T; Ochi H; Tateno C; Yoshizato K; Sakai A; Sakai Y; Honda M; Kaneko S; Wakita T; Chayama K
FEBS Lett; 2007 May; 581(10):1983-7. PubMed ID: 17466983
[TBL] [Abstract][Full Text] [Related]
17. A target on the move: innate and adaptive immune escape strategies of hepatitis C virus.
Thimme R; Lohmann V; Weber F
Antiviral Res; 2006 Mar; 69(3):129-41. PubMed ID: 16413618
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular biology of HCV infection and hepatitis.
Tang H; Grisé H
Clin Sci (Lond); 2009 Jun; 117(2):49-65. PubMed ID: 19515018
[TBL] [Abstract][Full Text] [Related]
19. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?
Missale G; Cariani E; Ferrari C
Dig Liver Dis; 2004 Nov; 36(11):703-11. PubMed ID: 15570998
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.
Ito T; Yasui K; Mukaigawa J; Katsume A; Kohara M; Mitamura K
Hepatology; 2001 Sep; 34(3):566-72. PubMed ID: 11526543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
